Journal of Antimicrobial Chemotherapy 2019

3 papers
The 2019 edition of the Journal of Antimicrobial Chemotherapy featured research focused on drug resistance patterns, antimicrobial stewardship, and the evaluation of alternative therapeutic agents. One study examined rifampicin and rifabutin resistance across 1,003 clinical isolates of Mycobacterium tuberculosis, providing data on resistance trends in tuberculosis. Other research addressed public health strategies, specifically analyzing electronic health records from the Clinical Practice Research Datalink to identify opportunities for reducing antibiotic prescribing for patients with chronic obstructive pulmonary disease (COPD) in primary care settings. Additionally, the journal included work on potential treatments for sexually transmitted infections, such as the evaluation of apramycin's efficacy against both spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae. These contributions, involving authors such as Jaimie Sixsmith, Megan Murray, and Andrew Hayward, reflect a focus on optimizing treatment protocols and investigating new antimicrobial candidates to address evolving resistance. This work highlights the intersection of clinical microbiology and data-driven primary care interventions.

Top Research Directions

The 6 research directions with Journal of Antimicrobial Chemotherapy 2019 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Countering the Molecular Mechanisms of Antibiotic Resistance133.3%
2Evaluating Clinical Outcomes Using Historical Patient Cohorts133.3%
3Integrating Chronic Comorbidities into Clinical Risk Stratification133.3%
4Iterative Multivariate Imputation for Incomplete Datasets133.3%
5Modeling Overdispersed Count Data with Negative Binomial Regression133.3%
6The Prescription-Consumption Gap in Real-World Clinical Data133.3%

Download all directions as CSV

Institutions

Institutions credited by Journal of Antimicrobial Chemotherapy 2019 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.

#InstitutionPapersShare
1University College London 1100.0%

Download all institutions as CSV

About this data

Papers. Journal of Antimicrobial Chemotherapy 2019 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 3 papers (33.3%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Antimicrobial Chemotherapy 2019”, https://lacuna.tiptreesystems.com/venue/journal-of-antimicrobial-chemotherapy/2019.

Impactful Papers

Papers from Journal of Antimicrobial Chemotherapy 2019 that shaped research clusters.

Influential

Papers

Title
Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae
Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD)
Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates